{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:41:05Z","timestamp":1757608865113,"version":"3.44.0"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The Thai Food and Drug Administration (TFDA) has approved direct oral anticoagulant (DOAC) dosing based on estimated creatinine clearance, eCrCl (Cockcroft\u2010Gault equation). However, other renal function equations are often used in practice for patients with kidney disease, leading to potential discrepancies in DOAC dosing recommendations. The actual DOAC dosing patterns in resource\u2010limited countries remain underreported. This cross\u2010sectional study included patients with renal impairment who were treated at the outpatient department of Siriraj Hospital, Mahidol University, Thailand. Patients received their first DOAC for atrial fibrillation from January 2019 to December 2022. The primary objective was to evaluate the percentage of DOAC prescriptions compliant with TFDA guidelines using eCrCl. We also examined dosing agreement when substituting estimated glomerular filtration rate, eGFR (CKD\u2010EPI) for eCrCl. Patient factors and the incidence of stroke and bleeding over a one\u2010year follow\u2010up were also assessed. A total of 326 patients and 1587 DOAC prescriptions were analyzed. The mean patient age was 79.1\u2009\u00b1\u20099.2\u2009years, with a mean eGFR of 45.6\u2009\u00b1\u20099.9\u2009mL\/min\/1.73\u2009m<jats:sup>2<\/jats:sup>. TFDA\u2010compliant dosing was observed in 68.2% of prescriptions. Dose disagreement between eGFR and eCrCl was 45%, with a trend toward overdosing using eGFR. An eGFR of less than 45\u2009mL\/min\/1.73\u2009m<jats:sup>2<\/jats:sup> was associated with dose discrepancies. Stroke and bleeding incidences were low, with no differences across DOAC types. While most Thai patients received appropriate DOAC dosing, one\u2010third did not comply with TFDA guidelines. Using eGFR instead of eCrCl may result in dosing differences, particularly in moderate to severe renal impairment.<\/jats:p>","DOI":"10.1111\/cts.70238","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T02:15:03Z","timestamp":1745633703000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of DOAC Dosing Among Various Renal Equations in Patients With Kidney Impairment and Elderly in Thailand"],"prefix":"10.1111","volume":"18","author":[{"given":"Sayamon","family":"Sukkha","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-2249","authenticated-orcid":false,"given":"Supatat","family":"Chumnumwat","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattaranun","family":"Thongsoi","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawiphon","family":"Sonsiri","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apisara","family":"Lohachatinante","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuttanun","family":"Kittikunkanyakit","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rattana","family":"Chawanasuntharapot","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine Siriraj Hospital Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-1018","authenticated-orcid":false,"given":"Junporn","family":"Kongwatcharapong","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Faculty of Medicine Siriraj Hospital Mahidol University  Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_10_2_1","DOI":"10.1016\/j.jacc.2019.08.1031"},{"doi-asserted-by":"publisher","key":"e_1_2_10_3_1","DOI":"10.1016\/j.kint.2023.10.018"},{"unstructured":"The Nephrology Society of Thailand \u201cClinical Practice Recommendation for the Evaluation and Management of Chronic Kidney Disease in Adults 2022 (Revised Version) \u201d (2022) https:\/\/www.nephrothai.org\/.","key":"e_1_2_10_4_1"},{"doi-asserted-by":"publisher","key":"e_1_2_10_5_1","DOI":"10.1056\/NEJMoa1107039"},{"doi-asserted-by":"publisher","key":"e_1_2_10_6_1","DOI":"10.1056\/NEJMoa0905561"},{"doi-asserted-by":"publisher","key":"e_1_2_10_7_1","DOI":"10.1056\/NEJMoa1310907"},{"doi-asserted-by":"publisher","key":"e_1_2_10_8_1","DOI":"10.1056\/NEJMoa1009638"},{"doi-asserted-by":"publisher","key":"e_1_2_10_9_1","DOI":"10.1016\/j.jacasi.2023.08.007"},{"doi-asserted-by":"publisher","key":"e_1_2_10_10_1","DOI":"10.33963\/KP.a2022.0046"},{"doi-asserted-by":"publisher","key":"e_1_2_10_11_1","DOI":"10.1111\/bcp.14535"},{"doi-asserted-by":"publisher","key":"e_1_2_10_12_1","DOI":"10.7326\/0003\u20104819\u2010145\u20104\u2010200608150\u201000004"},{"doi-asserted-by":"publisher","key":"e_1_2_10_13_1","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"doi-asserted-by":"publisher","key":"e_1_2_10_14_1","DOI":"10.1177\/1076029620987900"},{"unstructured":"\u201cEliquis (Apixaban). In Bangkok: Pfizer (Thailand) \u201d2015.","key":"e_1_2_10_15_1"},{"unstructured":"\u201cPradaxa (Dabigatran). In Bangkok: Boehringer Ingelheim (Thailand) Ltd \u201d2015.","key":"e_1_2_10_16_1"},{"unstructured":"\u201cLixiana (Edoxaban) in Bangkok: Daiichi Sankyo (Thailand) \u201d2023.","key":"e_1_2_10_17_1"},{"unstructured":"\u201cXarelto (Rivaroxaban). In Bangkok: Bayer Thai Co Ltd \u201d2014.","key":"e_1_2_10_18_1"},{"doi-asserted-by":"publisher","key":"e_1_2_10_19_1","DOI":"10.1111\/j.1538\u20107836.2005.01204.x"},{"doi-asserted-by":"publisher","key":"e_1_2_10_20_1","DOI":"10.1177\/0897190019828270"},{"doi-asserted-by":"publisher","key":"e_1_2_10_21_1","DOI":"10.1016\/j.amjmed.2016.05.041"},{"doi-asserted-by":"publisher","key":"e_1_2_10_22_1","DOI":"10.1007\/s40256\u2010021\u201000473\u2010x"},{"key":"e_1_2_10_23_1","first-page":"39","article-title":"Renal Function Estimates and Dosing of Direct Oral Anticoagulants in Stroke Patients With Atrial Fibrillation: An Observational Study","volume":"27","author":"Chen Y. T.","year":"2018","journal-title":"Acta Neurologica Taiwanica"},{"doi-asserted-by":"publisher","key":"e_1_2_10_24_1","DOI":"10.1016\/j.cjca.2018.04.019"},{"doi-asserted-by":"publisher","key":"e_1_2_10_25_1","DOI":"10.1161\/CIRCOUTCOMES.120.006852"},{"doi-asserted-by":"publisher","key":"e_1_2_10_26_1","DOI":"10.1002\/phar.1282"},{"doi-asserted-by":"publisher","key":"e_1_2_10_27_1","DOI":"10.1097\/TP.0000000000005098"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:15:55Z","timestamp":1756883755000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.70238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/cts.70238"],"URL":"https:\/\/doi.org\/10.1111\/cts.70238","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"type":"print","value":"1752-8054"},{"type":"electronic","value":"1752-8062"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"2024-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70238"}}